Your browser doesn't support javascript.
loading
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells.
Mitwasi, Nicola; Feldmann, Anja; Bergmann, Ralf; Berndt, Nicole; Arndt, Claudia; Koristka, Stefanie; Kegler, Alexandra; Jureczek, Justyna; Hoffmann, Anja; Ehninger, Armin; Cartellieri, Marc; Albert, Susann; Rossig, Claudia; Ehninger, Gerhard; Pietzsch, Jens; Steinbach, Jörg; Bachmann, Michael.
Afiliación
  • Mitwasi N; University Cancer Center (UCC) 'Carl Gustav Carus' TU Dresden, Tumor Immunology, Dresden, Germany.
  • Feldmann A; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • Bergmann R; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • Berndt N; German Cancer Consortium (DKTK), partner site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Arndt C; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • Koristka S; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • Kegler A; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • Jureczek J; University Cancer Center (UCC) 'Carl Gustav Carus' TU Dresden, Tumor Immunology, Dresden, Germany.
  • Hoffmann A; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • Ehninger A; GEMoaB Monoclonals GmbH, Dresden, Germany.
  • Cartellieri M; Cellex Patient Treatment GmbH, Dresden, Germany.
  • Albert S; University Cancer Center (UCC) 'Carl Gustav Carus' TU Dresden, Tumor Immunology, Dresden, Germany.
  • Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
  • Ehninger G; German Cancer Consortium (DKTK), partner site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Pietzsch J; Medical Clinic and Policlinic I, University Hospital 'Carl Gustav Carus', TU Dresden, Dresden, Germany.
  • Steinbach J; National Center for Tumor Diseases (NCT), Dresden, 'Carl Gustav Carus' TU Dresden, Dresden, Germany.
  • Bachmann M; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
Oncotarget ; 8(65): 108584-108603, 2017 Dec 12.
Article en En | MEDLINE | ID: mdl-29312553
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania